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Metabolomics reveals mouse
plasma metabolite responses to
acute exercise and effects of
disrupting AMPK-glycogen
interactions
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David I. Broadhurst 2, Nolan J. Hoffman 1* and Stacey N. Reinke 2*
1
Exercise and Nutrition Research Program, Mary MacKillop Institute for Health Research, Australian
Catholic University, Melbourne, VIC, Australia, 2Centre for Integrative Metabolomics and
Computational Biology, School of Science, Edith Cowan University, Joondalup, WA, Australia,
3
Australian National Phenome Centre and Centre for Computational and Systems Medicine, Health
Futures Institute, Murdoch University, Perth, WA, Australia

Introduction: The AMP-activated protein kinase (AMPK) is a master regulator of
energy homeostasis that becomes activated by exercise and binds glycogen, an
important energy store required to meet exercise-induced energy demands.
Disruption of AMPK-glycogen interactions in mice reduces exercise capacity
and impairs whole-body metabolism. However, the mechanisms underlying
these phenotypic effects at rest and following exercise are unknown.
Furthermore, the plasma metabolite responses to an acute exercise
challenge in mice remain largely uncharacterized.
Methods: Plasma samples were collected from wild type (WT) and AMPK double
knock-in (DKI) mice with disrupted AMPK-glycogen binding at rest and
following 30-min submaximal treadmill running. An untargeted
metabolomics approach was utilized to determine the breadth of plasma
metabolite changes occurring in response to acute exercise and the effects
of disrupting AMPK-glycogen binding.
Results: Relative to WT mice, DKI mice had reduced maximal running speed (p <
0.0001) concomitant with increased body mass (p < 0.01) and adiposity (p <
0.001). A total of 83 plasma metabolites were identiﬁed/annotated, with
17 metabolites signiﬁcantly different (p < 0.05; FDR<0.1) in exercised (↑6;
↓11) versus rested mice, including amino acids, acylcarnitines and steroid
hormones. Pantothenic acid was reduced in DKI mice versus WT. Distinct
plasma metabolite proﬁles were observed between the rest and exercise
conditions and between WT and DKI mice at rest, while metabolite proﬁles
of both genotypes converged following exercise. These differences in
metabolite proﬁles were primarily explained by exercise-associated increases
in acylcarnitines and steroid hormones as well as decreases in amino acids and
derivatives following exercise. DKI plasma showed greater decreases in amino
acids following exercise versus WT.
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Conclusion: This is the ﬁrst study to map mouse plasma metabolomic changes
following a bout of acute exercise in WT mice and the effects of disrupting
AMPK-glycogen interactions in DKI mice. Untargeted metabolomics revealed
alterations in metabolite proﬁles between rested and exercised mice in both
genotypes, and between genotypes at rest. This study has uncovered known
and previously unreported plasma metabolite responses to acute exercise in WT
mice, as well as greater decreases in amino acids following exercise in DKI
plasma. Reduced pantothenic acid levels may contribute to differences in fuel
utilization in DKI mice.
KEYWORDS

exercise metabolism, plasma metabolite, metabolomics, AMP-activated protein
kinase, glycogen, amino acids, acylcarnitines, pantothenic acid

1 Introduction

(Hoffman et al., 2020). These β1 W100A KI and β2 W98A KI
mutations were associated with disrupted whole-body and tissue
metabolism and impaired maximal running capacity in β2 W98A
KI mice relative to wild type (WT) mice. Considering both
AMPK β1 and β2 isoforms are expressed in the majority of
mouse tissues and cell types including liver and skeletal muscle
(Janzen et al., 2018), mice with KI mutations in both isoforms
(AMPK β1 W100A/β2 W98A double knock-in; DKI; Figure 1A)
were generated to investigate the phenotypic consequences of
disrupting whole-body AMPK-glycogen interactions at rest and
during exercise. DKI mice displayed impaired whole-body
metabolism and changes in energy substrate utilization
(i.e., reduced fat oxidation) associated with increased total
body and fat mass and altered tissue glycogen dynamics
(Janzen et al., 2021). Furthermore, these metabolic effects
were associated with reduced maximal exercise capacity in
DKI mice compared to WT (Janzen et al., 2022). Despite
recent progress in the understanding of metabolic and
physiological
effects
of
disrupting
AMPK-glycogen
interactions, the downstream changes in metabolic pathways
and molecular mechanisms underlying these effects remain
largely unknown.
Discovery-based untargeted metabolomics can be used to
investigate metabolic changes in response to acute exercise and in
association with whole-body disruption of AMPK-glycogen
binding. The metabolome reﬂects the cumulative changes that
result from layers of biological regulation involving the genome,
transcriptome and proteome, as well as their interactions with the
environment and physiological stimuli such as exercise (Belhaj
et al., 2021). Metabolomics therefore provides a snapshot of the
metabolic reactions in “real-time” (Dunn et al., 2011). Using
mass spectrometry-based untargeted metabolomic approaches,
metabolites across a wide range of metabolic pathways can be
simultaneously identiﬁed in blood and tissue samples, requiring
only minimal sample volumes. Using untargeted metabolomics,
we aimed to determine plasma metabolic responses to acute
treadmill running and characterize the effects of disrupting
AMPK-glycogen interactions on plasma metabolite proﬁles
both at rest and following exercise. We sought to identify

The beneﬁts of exercise on metabolic health are widely
appreciated. Exercise represents a substantial challenge to
cellular and whole-body energy homeostasis, and a
multitude of molecular metabolic responses including
changes in circulating metabolites occur in response to
exercise to help meet increased energy demands and
preserve homeostasis (Hawley et al., 2014). One of the key
regulators of energy homeostasis is the AMP-activated protein
kinase (AMPK), a pivotal cellular energy sensing kinase that
integrates intracellular and extracellular metabolic signals and
regulates numerous downstream metabolic pathways to
mobilize energy reserves and generate ATP, the energy
currency of the cell (Garcia and Shaw, 2017). Through
competitive binding of ATP, ADP and AMP, AMPK senses
cellular energy status. Decreases in cellular energy levels
(i.e., increased AMP/ATP ratio) in response to exercise lead
to activation of AMPK. Once activated, AMPK switches on
catabolic pathways including glycolysis and fat oxidation,
while concurrently switching off anabolic processes
including fat and protein synthesis (Garcia and Shaw,
2017). In addition, AMPK contains a carbohydrate binding
module (CBM) within its β subunit (existing in two isoforms;
β1 and β2) that allows AMPK to bind glycogen (Hudson et al.,
2003; Polekhina et al., 2003; Polekhina et al., 2005), an
important energy reserve of glucose utilized during exercise
(van Loon et al., 2001), thereby contributing to its cellular
energy sensing capacity (McBride et al., 2009).
A growing body of evidence has uncovered interactive roles
of AMPK and glycogen at the molecular, cellular and
physiological levels (Janzen et al., 2018), including
investigations using animal model systems with mutant forms
of AMPK that would not be feasible to study in humans. Recent
ﬁndings from our group demonstrated phenotypic effects of
disrupting AMPK’s glycogen binding capacity in vivo, using
AMPK β1 or β2 single knock-in (KI) mice in which amino
acid residues in either isoform CBM that mediate glycogen
binding were mutated (β1 W100A KI or β2 W98A KI)
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FIGURE 1
AMPK DKI mouse model and phenotypic effects of disrupting whole-body AMPK-glycogen interactions on maximal running speed and body
composition. (A) Schematic of WT mice with intact AMPK-glycogen binding and AMPK DKI mice in which critical tryptophan residues within the
AMPK β subunit isoforms that mediate glycogen binding (β1; predominantly expressed in mouse liver; and β2 predominantly expressed in mouse
skeletal muscle) have been mutated to alanine (β1 W100A and β2 W98A, respectively), resulting in whole-body disruption of AMPK-glycogen
binding; (B) Maximal running speed (m/min); (C) Total body mass (g); (D) Total lean mass (g); (E) Total fat mass (g). *: p < 0.05, **: p < 0.01, ****p <
0.0001; values are represented as mean ± SEM; n = 21–23 mice per group.

20% protein and 6% fat, Barastoc, Ridley Agriproducts,
Pakenham, Australia).
CRISPR/Cas9 gene editing was performed by the Mouse
Engineering Garvan/ABR (MEGA) Facility to generate wholebody AMPK Prkab1W100A (β1 W100A) and Prkab2W98A
(β2 W98A) single KI mice on a C57BL/6J background
(Hoffman et al., 2020). Homozygous single KI mice were
crossed to generate Prkab1W100A/Prkab2W98A DKI mice.
Breeding was performed using homozygous WT mice and
homozygous carriers of the DKI mutations, to generate the
homozygous WT and DKI mouse lines used in the present
study. Due to limited age-matched mouse cohort availability
and in order to maintain sufﬁcient female mice for breeding,
only male mice were used in the present study. Tail samples
were collected for conﬁrmatory genotyping performed by
TransnetYX (Cordova, TN, United States). All experiments
were performed in age-matched WT and DKI male mice
within an age range of 12–16 weeks, and mice from each
genotype were randomly assigned to the rested and
exercised experimental groups.

underlying molecular mechanisms that may contribute to the
metabolic phenotypic effects and reduced exercise capacity
observed in AMPK DKI mice.

2 Materials and methods
2.1 Animal models
All mouse procedures were performed under the approval of
the St. Vincent’s Hospital (Melbourne, Australia) Animal Ethics
Committee (approval numbers 025-15 and 011-19) in
accordance with NHMRC requirements and conforming to
the National Institutes of Health animal research guidelines
(NIH Publications No. 8023, revised 1978) and Australian
codes of animal research practice (8th Edition 2013). Mice
were kept in pathogen-free microisolator cages (2–5 mice per
cage) on standard 12:12-h dark-light cycles with controlled
temperature (21°C), humidity and bedding. Mice had ad
libitum access to water and standard chow diet (29% starch
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2.2 Study design

2.3 Metabolomics sample preparation

2.2.1 Treadmill acclimatization, body
composition analysis and maximal running
speed testing

Metabolomic analysis of mouse plasma samples was
performed at the Centre for Integrative Metabolomics and
Computational Biology, Edith Cowan University (Joondalup,
Western Australia, Australia) according to previously
established data acquisition, processing and analysis workﬂows
(Manaf et al., 2018). Plasma samples were thawed on ice and each
sample was separated into two 30 μl aliquots. A pooled quality
control (QC) sample was prepared by mixing 50 μl of remaining
plasma from each sample; the pooled sample was subsequently
divided into 30 μl aliquots. All prepared aliquots were then frozen
and stored at −80°C until analysis.
On the day of mass spectrometry-based metabolomic data
acquisition, plasma aliquots were thawed on ice, and protein
precipitation was performed prior to running two liquid
chromatography-based separation modes, as detailed below.
For hydrophilic interaction liquid chromatography (HILIC),
protein precipitation was performed by adding 90 μl of icecold liquid chromatography-mass spectrometry (LC-MS)
grade acetonitrile [3:1 (v/v)] containing isotopically labelled
standards of known concentration [1 ppm each: valine-d8,
tryptophan-d9, taurodeoxycholic acid-d4, leucine-13C1 and
sphingosine-d9 (d18:1)] to plasma samples and pooled QC
aliquots. For reversed-phase liquid chromatography (RPLC),
protein precipitation was performed by adding 90 μl of icecold LC-MS grade methanol to each 30 μl aliquot, with
identical internal standards. Samples were then mixed at
1,400 revolutions per min (rpm) for 2 min at 4°C and
centrifuged (Heraeus Megafuge 8R, Thermo Fisher Scientiﬁc.
AUS) for 20 min (1800 × g) at 4°C. 30 μl from each of the
resulting supernatants were transferred into LC-MS vials and
placed in an autosampler tray at 6°C. Prior to the run, the sample
injection sequence was block randomized by group (WT-Rest,
WT-Ex, DKI-Rest, DKI-Ex). LC-MS system suitability was
checked using the quality assurance methods described by
Broadhurst et al. (2018) and eight pooled QC samples were
injected at the beginning of the sequence to condition the
column. Pooled QC samples were then injected following each
block of eight experimental samples (i.e., every ninth injection)
which were used for assessment of analytical precision as
reported in (Broadhurst et al., 2018).

Prior to treadmill acclimatization and subsequent maximal
running speed testing, total body mass was determined, and body
composition was analyzed by magnetic resonance imaging using
the EchoMRI Body Composition Analysis 3-in-1 system
(EchoMRI, Houston, TX, United States). Mice were then
acclimatized to treadmill running (Exer 3/6, Columbus
Instruments, Columbus, OH, United States) for four
consecutive days at progressing speeds at a 0° incline. Manual
prodding using a soft bristle brush was performed to encourage
mice when necessary during both treadmill acclimatization and
testing. On day 1, mice were placed on a stationary treadmill for
5 min. On days 2 and 3, mice ran for 5 min at 5 and 10 m/min,
respectively. On day 4, mice ran for 15 min; including 5 min at
10, 12 and 15 m/min. The following day, mice underwent
incremental maximal running capacity testing during which
they ran for 2 min at 10 m/min, after which the speed was
increased by 1 m/min every 2 min until exhaustion (i.e., when
mice were unable to continue running despite repeated manual
prodding). Both WT (n = 21) and DKI (n = 23) mice were then
randomly assigned to either the exercised or rested control group,
with a total of four experimental groups: WT rested (WT-Rest;
n = 10), WT exercised (WT-Ex; n = 11), DKI rested (DKI-Rest;
n = 13) and DKI exercised (DKI-Ex; n = 10).

2.2.2 Acute treadmill exercise bout and blood
sample collection
Following two to 3 days of recovery after maximal running
capacity testing, mice randomly assigned to the exercise group
completed a single bout of running for 30 min at 70% of
individual maximal speed at 0° treadmill incline, while rested
control mice remained in their home cage. This 70% of
individual maximal running speed was used due to the mix
of carbohydrate and fat energy sources expected to be utilized
at this speed (Torgan et al., 1990; McClelland, 2004). Upon
completion of the rest period or acute exercise bout, rested
and exercised mice were immediately placed in a CO2
chamber for ~10 s prior to a cardiac puncture to allow
sufﬁcient blood volume collection. Blood collections were
performed in the fed state between 0800 and 1000 h in
both the exercised and rested groups, corresponding to the
beginning of the light phase. Blood was collected via cardiac
puncture using a 23G needle attached to a 1 ml syringe,
immediately transferred to 1.3 ml lithium-heparin coated
tubes (Sarstedt, Nümbrecht, Germany), inverted 10 times
and placed on ice. Tubes were then centrifuged at 2000 × g
for 10 min at 4°C, with total time on ice consistent for all
collected samples. The resulting plasma supernatant was then
divided into 300 μl aliquots and stored at −80°C until analysis.

Frontiers in Molecular Biosciences

2.4 Data acquisition: Liquid
chromatography–high resolution mass
spectrometry
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Samples were analyzed using the Dionex UltiMate 3000
platform which comprises an ultra-high performance liquid
chromatography pump coupled to a heated electrospray Q
Exactive Focus Orbitrap mass spectrometer (Thermo
Scientiﬁc, San Jose, CA, United States). Data were acquired in
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the blanks were subtracted from the samples using the “mark
background compounds” node.
Metabolite identiﬁcation/annotation was also performed in
Compound Discoverer in accordance with the Metabolomics
Standard Initiative (MSI) levels (Sumner et al., 2007). Details on
identiﬁcations/annotations can be found in Supplementary Table
S2. Quality control-regularized spline correction (QC-RSC) was
used to correct analytical signal drift (Kirwan et al., 2013).
Following standard protocols (Broadhurst et al., 2018),
metabolites with RSDQC > 20% or a Dispersion-ratio
(D-ratio) > 30% were removed from further statistical
analyses based on their failure to meet acceptable
measurement precision. Eight hemolyzed plasma samples were
removed from the full sample set to prevent potential
confounding effects of sample hemolysis on the metabolomic
analysis.

full scan mode at a mass resolution of 70,000 [Full Width at Half
Maximum (FWHM) at mass to charge ratio (m/z) of 200], over a
scan range of m/z 70–1000. Tandem mass spectrometry (MS/
MS) was performed on all QC samples using data-dependent
acquisition (DDA) in “discovery” mode using the following
settings: resolution = 17,500; isolation width = 3.0 m/z;
stepped collision energy = 15, 30 eV. Source and ion transfer
conditions were as follows: sheath gas = 35 (arbitrary units),
auxiliary gas = 10 (arbitrary units), source heater 350°C, capillary
temperature = 350°C, ion spray voltage = 2.5 kV (negative ion
mode) and 3.0 kV (positive ion mode). The automatic gain
control target was set at 3 × 10–6.
Two chromatography-based separation methods were
applied to each sample. Polar metabolites were separated by
HILIC chromatography in positive mode (HILIC POS), using an
ACQUITY UPLC BEH Amide column (2.1 × 100 mm, 1.7 μm;
Waters, Milford, MA, United States) with a ﬂow rate of 400 μl/
min and the following mobile phases: mobile phase A (10 mM
ammonium formate in water +50 mM formic acid) and mobile
phase B (10 mM ammonium formate in 90% Acetonitrile
+50 mM formic acid). A 15-min elution gradient was applied
as follows: 0 min; 100% B; 1 min 1% B; 8–9 min 60% B; 10 min
100% B through to 15 min. A 6 μl sample injection volume was
applied. Non-polar metabolites were separated by RPLC on a
Hypersil GOLD column (2.1 × 100 mm, 1.9 μm; Thermo Fisher
Scientiﬁc, Runcorn, UK), with a ﬂow rate 300 μl/min using the
following mobile phases: mobile phase A (water +0.1% formic
acid) and mobile phase B (Acetonitrile +0.1% formic acid). A
15-min elution gradient was applied as follows: 0 min 1% B;
1 min 1% B; 2 min 50% B; 9–10 min 99% B; 10.5 min 1% B
through to 15 min. A 6 μl sample injection was applied, and
samples were collected in positive and negative mode. Xcalibur
software (Thermo Fisher Scientiﬁc v4.3) was used for data
acquisition. Before analysis, commercially purchased
calibrant solutions (negative and positive ion calibration
solutions) from Thermo Fisher Scientiﬁc (San Jose, CA,
United States) were used to externally calibrate the Orbitrap
mass spectrometer.

™

2.6 Statistical analyses
For statistical analyses of mouse body mass, body composition
and maximal running speed, p-values were calculated using
unpaired Student’s t-tests (WT versus DKI) and Welch’s
correction was applied when applicable, with p < 0.05 considered
statistically signiﬁcant. Outlier identiﬁcation was performed using
the Grubb’s test or the ROUT method. Statistical tests for these
measures were performed using GraphPad Prism software version
8.4.3 (GraphPad Software, San Diego, CA).
For statistical analyses of the metabolomics dataset, two-way
ANOVA was performed to test the null hypothesis (i.e., no
differences between rested/exercised conditions and/or WT/
DKI genotypes) for each individual identiﬁed/annotated
metabolite. Estimation of the false discovery rate (FDR) due
to multiple comparisons was performed using the Storey FDR
method (Storey, 2002), and p-values < 0.05 with a FDR <0.1 were
considered statistically signiﬁcant.
To assess the structured similarities between metabolite
concentrations across the complete data set, hierarchical
cluster analysis (HCA) was performed using Pearson’s
correlation coefﬁcient as the similarity measure, and Ward’s
linkage method (Ward and Hook, 1963). The lowest linkages
(i.e., closest metabolite clusters) within the HCA dendrogram
indicate metabolites that display the most similar responses. The
resulting visualization labeled by metabolite signiﬁcance,
indicates metabolites of particular interest displaying similar
(correlated) changes.
To model and visualize the multivariate discrimination
between the four experimental groups, all metabolites were
combined into a single data matrix and applied to principal
component–canonical variates analysis (PC-CVA) (Krzanowski,
1988). PC-CVA uses the (multivariate) covariance between
metabolite concentration and outcome classiﬁcation to test the
statistical signiﬁcance of the mean differences. Multivariate data

2.5 Data processing
Following data acquisition, spectral processing was
performed (i.e., HILIC POS and C18 POS and C18 NEG)
in Compound Discoverer 3.1 (Thermo Scientiﬁc, San Jose,
CA, United States) using an untargeted metabolomics
workﬂow. Compound Discoverer version 3.1 was utilized
for total ion chromatograms alignment along retention times
(RT) based on an adaptive curve, with a 5-ppm mass
tolerance and a maximum shift of 0.5 min. Detected
features with a signal-to-noise ratio >5 and an
intensity ≥1,000,000 in each dataset were merged into
compounds according to ion adducts. Ions detected within

™

™
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Column &
mode

Metabolite

Molecular
formula

Molecular
weight

RT
(min)

RSDQC p-value
G

FDR
G

p-value
C

FDR
C

p-value
GxC

FDR
GxC

MSI
ID

Cluster

C18POS

alpha-Linolenic acid

C18 H30 O2

278.2241

8.27

10.918

0.911

0.454

0.657

0.658

0.429

0.519

1

A

C18NEG

C18:1 fatty acid

C18 H34 O2

282.2551

9.67

6.993

0.230

0.263

0.355

0.440

0.548

0.529

2

A

C18POS

Arachidonic acid

C20 H32 O2

304.2401

8.72

9.285

0.321

0.295

0.791

0.691

0.294

0.542

2

A

C18POS

2-Arachidonoyl glycerol

C23 H38 O4

378.2764

8.17

13.736

0.250

0.260

0.915

0.685

0.093

0.444

2

A

C18POS

Monoolein

C21 H40 O4

356.2924

8.93

10.887

0.237

0.258

0.985

0.685

0.074

0.377

2

A

HILICPOS

Lyso-PAF C16

C24 H52 N O6 P

481.3527

2.34

13.091

0.006

0.145

0.323

0.432

0.182

0.484

1

A

C18NEG

Bile acid (C26H45NO7S)

C26 H45 N O7 S

515.2906

3.63

3.804

0.014

0.222

0.846

0.702

0.356

0.483

3

A

C18NEG

Stercobilin

C33 H46 N4 O6

594.3399

4.75

8.386

0.259

0.264

0.858

0.695

0.983

0.661

2

A

C18NEG

Lithocholyltaurine

C26 H45 N O5 S

483.3010

4.61

4.708

0.185

0.271

0.952

0.675

0.381

0.497

1

A

C18POS

Taurochenodesoxycholic acid

C26 H45 N O6 S

499.2965

4.13

2.108

0.052

0.220

0.992

0.683

0.251

0.538

1

A

C18NEG

Chenodeoxycholic acid glycine
conjugate

C26 H43 N O5

449.3133

4.29

4.633

0.091

0.225

0.880

0.681

0.201

0.496

1

A
A

06

C18POS

Glycocholic acid

C26 H43 N O6

465.3088

4.25

6.866

0.081

0.211

0.924

0.684

0.175

0.528

1

C18NEG

Glycoursodeoxycholic acid

C26 H43 N O5

449.3134

4.92

2.424

0.080

0.221

0.773

0.692

0.048

0.318

2

A

C18NEG

Riboﬂavin

C17 H20 N4 O6

376.1374

3.33

5.997

0.151

0.294

0.940

0.674

0.102

0.399

2

A

C18NEG

Oxidized glutathione

C20 H32 N6 O12 S2

612.1506

1.62

7.792

0.339

0.299

0.863

0.691

0.172

0.545

1

A

C18POS

Reduced glutathione

C10 H17 N3 O6 S

307.0836

1.30

15.021

0.019

0.177

0.405

0.493

0.335

0.519

1

A
B

Glycylproline

C7 H12 N2 O3

172.0847

1.29

8.734

0.015

0.178

0.869

0.688

0.318

0.516

1

HILICPOS

Propionylcarnitine

C10 H19 N O4

217.1312

3.25

8.578

0.036

0.212

0.105

0.238

0.849

0.657

1

B

C18NEG

Bile acid (C24H40O5)

C24 H40 O5

408.2866

4.12

3.099

0.053

0.208

0.913

0.691

0.696

0.586

3

B

C18NEG

Chenodeoxycholic acid

C24 H40 O4

392.2919

4.89

7.111

0.342

0.297

0.133

0.266

0.152

0.506

1

B

C18POS

Nutriacholic acid

C24 H38 O4

390.2767

5.09

5.142

0.285

0.272

0.133

0.259

0.406

0.501

1

B

C18NEG

Deoxycholic acid

C24 H40 O4

392.2921

5.75

4.756

0.201

0.262

0.252

0.381

0.096

0.426

2

B

HILICPOS

Hypotaurine

C2 H7 N O2 S

109.0199

5.88

12.036

0.523

0.340

0.876

0.686

0.808

0.632

1

B

C18NEG

Thymidine

C10 H14 N2 O5

242.0897

2.98

5.315

0.991

0.473

0.480

0.554

0.245

0.563

2

B

HILICPOS

Acetylcarnitine

C9 H17 N O4

203.1154

4.11

11.964

0.620

0.368

0.245

0.380

0.348

0.492

1

B

HILICPOS

Bilirubin

C33 H36 N4 O6

584.2620

0.91

6.493

0.895

0.451

0.794

0.684

0.073

0.404

2

B

HILICPOS

Carnitine

C7 H15 N O3

161.1049

4.11

11.349

0.384

0.321

0.329

0.430

0.127

0.470

1

C

HILICPOS

Melatonin

C13 H16 N2 O2

232.1209

0.82

10.277

0.041

0.193

0.256

0.379

0.301

0.527

1

C

C18POS

Cytosine

C4 H5 N3 O

111.0435

1.30

4.534

0.454

0.322

0.024

0.088

0.963

0.661

2

C

C18POS

Cytidine

C9 H13 N3 O5

243.0853

1.29

6.709

0.515

0.345

0.983

0.690

0.925

0.655

1

C
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TABLE 1 Summary of the metabolites identiﬁed/annotated from WT and DKI mouse plasma. A total of 83 plasma metabolites were identiﬁed/annotated, including 17 metabolites signiﬁcantly changed by
condition (i.e., exercise versus rest) and one metabolite signiﬁcantly changed by genotype (i.e., DKI versus WT) based on univariate analysis. Statistically signiﬁcant values (p < 0.05 and/or FDR<0.1)
appear in bold text. C, condition; G, genotype; G × C, interaction between condition and genotype; FDR. false discovery rate; MSI, Metabolomics Standards Initiative; RSDQC, relative standard deviation in
quality control samples; RT, retention time.

Column &
mode

Metabolite

Molecular
formula

Molecular
weight

RT
(min)

RSDQC p-value
G

FDR
G

p-value
C

FDR
C

p-value
GxC

FDR
GxC

MSI
ID

Cluster

C18POS

Kynurenic acid

C10 H7 N O3

189.0423

3.24

2.819

0.867

0.442

0.198

0.338

0.918

0.657

1

C

C18POS

Spermidine

C7 H19 N3

145.1579

0.77

7.732

0.530

0.335

0.266

0.377

0.733

0.609

1

C

HILICPOS

Stearoylethanolamide

C20 H41 N O2

327.3132

0.66

7.501

0.281

0.274

0.126

0.268

0.341

0.505

1

C

HILICPOS

Dipalmitoylphosphatidylcholine

C40 H80 N O8 P

733.5612

0.98

6.336

0.635

0.363

0.057

0.170

0.796

0.631

2

C

C18NEG

N-Acetyltyrosine

C11 H13 N O4

223.0835

3.22

8.121

0.430

0.325

0.105

0.231

0.691

0.605

1

C

C18POS

N-Acetyltryptophan

C13 H14 N2 O3

246.1002

3.66

4.804

0.552

0.344

0.010

0.044

0.547

0.536

1

C

C18POS

Progesterone

C21 H30 O2

314.2238

6.38

6.020

0.165

0.298

1.09E-09

3.72E08

0.030

0.334

1

C

C18POS

Corticosterone

C21 H30 O4

346.2142

4.36

5.214

0.414

0.329

5.11E-10

3.48E08

0.889

0.665

2

C

HILICPOS

Palmitoylcarnitine

C23 H45 N O4

399.3339

0.97

6.812

0.944

0.461

0.001

0.005

0.895

0.662

1

C

C18NEG

16-Hydroxyhexadecanoic acid

C16 H32 O3

272.2347

8.44

6.147

0.527

0.338

0.097

0.228

0.256

0.533

2

C

07

Hexanoylcarnitine

C13 H25 N O4

259.1777

1.72

13.234

0.738

0.402

0.024

0.092

0.495

0.540

2

C

Hexadecanedioic acid

C16 H30 O4

286.2140

6.12

12.155

0.210

0.266

0.750

0.681

0.953

0.660

2

C

C18POS

Histamine

C5 H9 N3

111.0799

0.80

2.585

0.458

0.320

0.677

0.659

0.866

0.654

1

C

HILICPOS

Methylimidazoleacetic acid

C6 H8 N2 O2

140.0585

5.26

10.576

0.495

0.336

0.304

0.423

0.748

0.607

1

C

HILICPOS

Prolylleucine/Leucylproline

C11 H20 N2 O3

228.1468

5.10

13.965

0.357

0.304

0.503

0.571

0.977

0.663

2

D

HILICPOS

Creatine

C4 H9 N3 O2

131.0694

5.84

6.064

0.273

0.272

0.197

0.343

0.396

0.507

1

D

C18POS

Methylthioadenosine

C11 H15 N5 O3 S

297.0894

3.19

2.489

0.169

0.282

0.339

0.428

0.607

0.561

1

D

C18NEG

Fructose 6-phosphate

C6 H13 O9 P

260.0290

0.78

6.551

0.113

0.252

0.677

0.668

0.504

0.524

1

D

C18POS

Serotonin

C10 H12 N2 O

176.0949

2.92

4.198

0.141

0.287

0.713

0.674

0.642

0.586

1

D

C18NEG

12-HETE

C20 H32 O3

320.2346

6.83

5.510

0.600

0.365

0.725

0.676

0.589

0.552

1

D

C18POS

Eicosapentaenoic acid

C20 H30 O2

302.2243

6.83

6.254

0.438

0.326

0.683

0.655

0.692

0.598

2

D

HILICPOS

Hypoxanthine

C5 H4 N4 O

136.0385

3.64

10.615

0.441

0.323

0.266

0.385

0.462

0.549

1

D

HILICPOS

Adenosine

C10 H13 N5 O4

267.0961

2.25

17.382

0.577

0.355

0.192

0.345

0.574

0.548

1

D

C18NEG

Guanosine monophosphate

C10 H14 N5 O8 P

363.0571

1.27

6.942

0.170

0.275

0.507

0.557

0.694

0.592

1

D

C18POS

Adenosine monophosphate

C10 H14 N5 O7 P

347.0631

0.90

1.401

0.691

0.385

0.803

0.684

0.682

0.614

1

D

C18POS

Oleamide

C18 H35 N O

281.2714

9.16

4.790

0.236

0.263

0.433

0.508

0.738

0.606

1

E

C18POS

Hexadecanamide

C16 H33 N O

255.2559

9.23

8.763

0.167

0.290

0.556

0.591

0.484

0.555

2

E

HILICPOS

Nicotinamide 1-oxide

C6 H6 N2 O2

138.0426

2.04

4.087

0.797

0.429

0.777

0.688

0.486

0.539

2

E

C18POS

Niacinamide

C6 H6 N2 O

122.0481

1.01

11.716

0.420

0.328

0.892

0.682

0.314

0.536

1

E

HILICPOS

4-Guanidinobutyric acid

C5 H11 N3 O2

145.0851

4.47

15.185

0.854

0.444

0.072

0.195

0.175

0.506

2

E
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TABLE 1 (Continued) Summary of the metabolites identiﬁed/annotated from WT and DKI mouse plasma. A total of 83 plasma metabolites were identiﬁed/annotated, including 17 metabolites signiﬁcantly
changed by condition (i.e., exercise versus rest) and one metabolite signiﬁcantly changed by genotype (i.e., DKI versus WT) based on univariate analysis. Statistically signiﬁcant values (p < 0.05 and/or
FDR<0.1) appear in bold text. C, condition; G, genotype; G × C, interaction between condition and genotype; FDR. false discovery rate; MSI, Metabolomics Standards Initiative; RSDQC, relative standard
deviation in quality control samples; RT, retention time.

Molecular
formula

Molecular
weight

RT
(min)

RSDQC p-value
G

FDR
G

p-value
C

FDR
C

p-value
GxC

08

Column &
mode

Metabolite

FDR
GxC

MSI
ID

C18NEG

Indoxyl sulfate

C8 H7 N O4 S

213.0087

3.27

4.325

0.404

0.326

0.543

0.587

0.860

0.658

1

E

C18POS

Phenylacetylglycine

C10 H11 N O3

193.0740

3.52

5.660

0.671

0.379

0.228

0.362

0.909

0.665

1

E

C18POS

2-Aminooctanoic acid

C8 H17 N O2

159.1260

3.52

3.860

0.197

0.272

0.224

0.364

0.317

0.527

1

E

C18POS

Tryptophan

C11 H12 N2 O2

204.0898

3.23

4.157

0.216

0.259

0.339

0.435

0.401

0.503

1

E

C18POS

Indole

C8 H7 N

117.0580

3.23

5.123

0.170

0.266

0.412

0.492

0.520

0.533

1

E

C18POS

Indoleacetic acid

C10 H9 N O2

175.0633

3.84

6.904

0.404

0.332

0.824

0.693

0.273

0.534

1

E

C18POS

3-Indolepropionic acid

C11 H11 N O2

189.0789

4.05

8.222

0.297

0.278

0.030

0.101

0.917

0.663

1

E

C18NEG

C18:2 fatty acid

C18 H32 O2

280.2398

6.34

3.507

0.424

0.325

0.050

0.154

0.296

0.533

3

E

C18POS

Sphingosine 1-phosphate

C18 H38 N O5 P

379.2484

5.78

2.156

0.073

0.245

0.005

0.028

0.690

0.612

1

E

C18POS

Pantothenic acid

C9 H17 N O5

219.1105

3.06

3.550

0.001

0.070

5.50E-04

0.003

0.287

0.545

1

F

C18POS

Methionine

C5 H11 N O2 S

149.0510

1.31

5.523

0.939

0.463

3.13E-04

0.002

0.026

0.347

1

F

C18POS

Ornithine

C5 H12 N2 O2

132.0899

0.80

1.918

0.223

0.261

1.06E-04

0.001

0.099

0.410

1

F

C18POS

Histidine

C6 H9 N3 O2

155.0695

0.81

2.298

0.029

0.227

1.48E-05

2.02E-04

0.266

0.537

1

F

C18POS

Phenylalanine

C9 H11 N O2

165.0789

2.96

5.817

0.726

0.400

0.084

0.205

0.327

0.519

1

F

HILICPOS

Tyrosine

C9 H11 N O3

181.0737

5.34

6.177

0.053

0.192

0.180

0.331

0.039

0.368

1

F

HILICPOS

Proline

C5 H9 N O2

115.0634

5.33

10.072

0.094

0.219

0.024

0.096

0.009

0.150

2

F

C18POS

Arginine

C6 H14 N4 O2

174.1116

0.84

3.661

0.631

0.369

0.007

0.032

0.003

0.198

1

F

HILICPOS

Isoleucine/Leucine

C6 H13 N O2

131.0946

4.78

6.852

0.604

0.363

1.08E-04

9.19E-04

0.041

0.344

1

F

C18POS

Pipecolic acid

C6 H11 N O2

129.0791

0.80

6.023

0.076

0.237

2.70E-06

6.12E-05

0.005

0.173

1

F

C18POS

Lysine

C6 H14 N2 O2

146.1055

0.80

3.389

0.121

0.258

3.52E-06

5.99E-05

0.007

0.160

1

F

C18POS

Glycerophospho-N-palmitoyl
ethanolamine (GP-NPEA)

C21 H44 N O7 P

453.2853

6.82

2.864

0.244

0.260

1.96E-04

0.001

0.051

0.306

2

F

C18POS

Threonine/Homoserine

C4 H9 N O3

119.0583

0.88

2.437

0.480

0.330

0.070

0.199

0.043

0.314

1

F

C18POS

Testosterone

C19 H28 O2

288.2085

5.04

9.679

0.211

0.260

0.130

0.268

0.525

0.522

1

F
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TABLE 1 (Continued) Summary of the metabolites identiﬁed/annotated from WT and DKI mouse plasma. A total of 83 plasma metabolites were identiﬁed/annotated, including 17 metabolites signiﬁcantly
changed by condition (i.e., exercise versus rest) and one metabolite signiﬁcantly changed by genotype (i.e., DKI versus WT) based on univariate analysis. Statistically signiﬁcant values (p < 0.05 and/or
FDR<0.1) appear in bold text. C, condition; G, genotype; G × C, interaction between condition and genotype; FDR. false discovery rate; MSI, Metabolomics Standards Initiative; RSDQC, relative standard
deviation in quality control samples; RT, retention time.
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is projected into a two-dimensional subspace (canonical variate
axes) reﬂecting the combination of metabolites that best
discriminate the labeled groups. Results are visualized via: 1) a
scores plot, with 95% conﬁdence intervals (CI) of the mean from
each group indicating signiﬁcant differences, and 2) a coefﬁcients
plot indicating the contribution importance of each metabolite to
each canonical variate. Overﬁtting was avoided by using 5-fold cross
validation to choose the optimal number of principal components to
apply to the CVA model. 95% CI for the model coefﬁcients were
calculated using bootstrap resampling (Hastie et al., 2009). Prior to
all statistical analyses, metabolite proﬁles were log10 transformed and
scaled to unit variance (autoscaled), allowing each metabolite to be
objectively compared with no bias due to large differences in
metabolite concentration. Statistical analyses of the metabolomic
dataset were performed using MATLAB package version R2021b
(MathWorks, Natick, MA).

3.2.1 Clustering of correlated metabolites
Hierarchical clustering of the 83 metabolites, based on pairwise Pearson’s correlation similarity, resulted in six clusters
reﬂecting different observed interaction between genotype and
exercise. The results are displayed as a circular dendrogram
(Figure 2A). The averaged z-score metabolite responses for
each cluster are presented in Figure 2B. The average response
for metabolites in Cluster A (16 metabolites, including fatty and
bile acids) was non-signiﬁcant but showed an interaction
between genotype and exercise such that during rest the DKI
metabolite level was greater than the WT level, but those levels
converged during exercise. Cluster B (10 metabolites,
including bile acids, acetylcarnitine and hypotaurine), again
non-signiﬁcant, showed the opposite trend (converged at rest
and lower WT following exercise). Cluster C (18 metabolites,
including steroid hormones and acylcarnitines), showed a
signiﬁcant increase in metabolite levels associated with
exercise in both genotypes (p = 2 × 10−5). Cluster D
(11 metabolites, including nucleotides and derivatives, lipid
species and creatine) and Cluster E (14 metabolites, including
lipid species, tryptophan and derivatives) showed similar nonsigniﬁcant trends as Cluster A and B but with the WT
metabolite levels greater than DKI. Cluster F (14 metabolites,
including amino acids and derivatives, pantothenic acid and
testosterone) showed a signiﬁcant interaction between
genotype and exercise (p = 4 × 10−4) such that the WT
metabolite levels remain constant and the DKI metabolite
levels signiﬁcantly decrease in association with exercise.
Clusters C and F drove the metabolite proﬁle response to
exercise intervention; p-values of all metabolite clusters are
presented in Supplementary Table S3.

®

3 Results
3.1 AMP-activated protein kinase double
knock-in mice exhibit increased total body
mass, fat mass and reduced maximal
running speed
Compared to age-matched WT mice (n = 21), DKI mice (n =
23) with whole-body disruption of AMPK-glycogen binding
(Figure 1A) displayed ~20% reduction in maximal running speed
(p < 0.0001, Figure 1B). DKI mice had increased total body mass
(~10%, p < 0.01, Figure 1C) associated with increased whole-body
fat mass (~65%, p < 0.001) but no differences in lean mass (Figures
1D,E) relative to WT mice.

3.2.2 Principal component-canonical variate
analysis

3.2 Metabolomics reveals plasma
metabolites affected by acute treadmill
exercise and/or AMP-activated protein
kinase double knock-in genotype

PC-CVA was performed to determine between-group
multivariate differences in plasma metabolite proﬁles with
respect to condition and genotype (Figure 3A). Overall, ~65%
of the total variance in the overall metabolomics dataset was
explained by canonical variate (CV) 1, while CV2 explained ~3%
of the total variance. The PC-CVA scores plot showed signiﬁcant
differences in the multivariate mean between the rested and
exercised conditions for both WT and DKI, as well as signiﬁcant
differences between WT and DKI plasma at rest, but no
signiﬁcant difference between WT and DKI following exercise.
CV1 particularly demonstrates a more pronounced change in
metabolic proﬁle in DKI rested versus exercise, compared to WT
rested versus exercised. The rested WT sample shows little
change (sitting at the origin of the plot) relative to which the
rested DKI sample are signiﬁcantly different. When both
genotypes are exercised their metabolic proﬁles change
signiﬁcantly but converge such that there was no signiﬁcant
difference between the exercised WT and DKI samples. The
contribution of each metabolite (with 95% conﬁdence intervals)

A total of 83 metabolites were identiﬁed/annotated following data
processing and cleaning steps and according to the standard reporting
guidelines from the Metabolomics Society Initiative (Sumner et al.,
2007). Two-way ANOVA revealed 17 metabolites were signiﬁcantly
different (p < 0.05; FDR <0.1) between conditions (rested versus
exercised) and only one metabolite signiﬁcantly different between
genotypes (WT versus DKI). All identiﬁed/annotated metabolites, in
addition to their molecular characteristics and respective statistical
relationships are listed in Table 1. Furthermore, Table 2 reports
metabolite change directionality, median fold-change (FC) and
95% conﬁdence intervals (CI) of these 17 metabolites that
signiﬁcantly changed between experimental groups along with
their associated pathways. All metabolite information and statistics
are reported in Supplementary Tables S1–S3.
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TABLE 2 Summary of the 17 metabolites signiﬁcantly changed by exercise and/or genotype. A total of six metabolites signiﬁcantly increased and
11 metabolites signiﬁcantly decreased following exercise, at the univariate level. Increased metabolites primarily consisted of acylcarnitines and
steroid hormones, while decreased metabolites predominantly consisted of amino acids and derivatives. Only pantothenic acid was signiﬁcantly
decreased in DKI versus WT mice at the univariate level. CI: conﬁdence interval; FC: fold-change; ↑: increase; ↓: decrease.

Metabolite

Exercise vs.
Rest

DKI vs. WT

Pathway

Median FC and 95%
CI (WT)

Median FC and 95%
CI (DKI)

Cluster

↑Cytosine

Pyrimidines

1.11 (0.78–1.62)

1.07 (0.95–1.43)

C

↑N-Acetyltryptophan

Amino acids and derivatives

1.25 (0.83–2.07)

1.60 (1.01–2.78)

C

↑Progesterone

Steroid hormones

1.98 (1.13–2.39)

2.48 (1.87–3.30)

C

↑Corticosterone

Steroid hormones

4.74 (2.99–15.01)

5.79 (3.92–23.90)

C

↑Palmitoylcarnitine

Acylcarnitines

1.37 (0.95–1.94)

1.73 (1.31–2.94)

C

↑Hexanoylcarnitine

Acylcarnitines

1.31 (0.83–2.08)

1.48 (1.01–2.01)

C

↓Sphingosine 1phosphate

Sphingolipids

0.86 (0.74–0.97)

0.90 (0.74–1.00)

E

↓Pantothenic acid

Vitamins and co-factors

0.78 (0.54–1.03)

0.79 (0.72–0.88)

F

↓Methionine

Amino acids and derivatives

0.90 (0.73–1.07)

0.73 (0.68–0.90)

F

↓Ornithine

Amino acids and derivatives

0.75 (0.57–1.05)

0.51 (0.38–0.67)

F

↓Histidine

Amino acids and derivatives

0.67 (0.50–1.00)

0.67 (0.49–0.82)

F

↓Proline

Amino acids and derivatives

1.25 (0.90–1.56)

0.60 (0.48–0.83)

F

↓Arginine

Amino acids and derivatives

1.02 (0.86–1.40)

0.71 (0.53–0.86)

F

↓Isoleucine/leucine

Amino acids and derivatives

0.89 (0.69–1.04)

0.69 (0.54–0.80)

F

↓Pipecolic acid

Amino acids and derivatives

0.83 (0.67–1.02)

0.57 (0.48–0.78)

F

↓Lysine

Amino acids and derivatives

0.78 (0.68–0.93)

0.59 (0.52–0.75)

F

↓GP-NPEA

Glycerophospholipids

0.96 (0.81–1.19)

0.77 (0.67–0.91)

F

Metabolite

Pathway

Median fold change and 95% CI
(rest)

Median fold change and 95%
CI (exercise)

Cluster

↓Pantothenic acid

Vitamins and co-factors

0.82 (0.67–0.97)

0.83 (0.61–0.98)

F

and physiological effects of the AMPK KI and DKI mutations
(Hoffman et al., 2020; Janzen et al., 2021; Janzen et al., 2022),
remain unknown. Furthermore, how an acute bout of exercise
affects the plasma metabolome in widely used mouse models
such as WT C57BL/6J mice, as well as the underlying metabolic
pathways that contribute to these exercise-induced changes in
plasma metabolite signatures has not been determined. In this
study, we ﬁrst reproduced the ﬁndings in AMPK DKI mice
showing increased total body mass and fat mass (Janzen et al.,
2021) and reduced maximal running speed (Janzen et al., 2022)
relative to WT control mice (Figures 1B–E). We then performed
metabolomics analysis on the plasma of WT and DKI mice both
at rest and after acute exercise to investigate the metabolic
mechanisms underlying increased adiposity and reduced
exercise capacity in DKI mice. The metabolomics analyses
revealed a signiﬁcant mean metabolic difference between WT
and DKI at rest but not after exercise, and a signiﬁcant mean
difference between rest and exercise in both genotypes. Cluster C
metabolites (acylcarnitines, steroid hormones) increased
signiﬁcantly in both genotypes in association with exercise. In
Cluster F (amino acids and derivatives), there was a signiﬁcant
interaction between genotype and exercise.

to CV1 and CV2 are presented in Supplementary Figure S1
(signiﬁcant metabolites indicated in red). Those metabolites
observed to be signiﬁcantly contributing to the model are
summarized in Figure 3B. Here, the direction of each
metabolite relative to the origin can be mapped to similar
directions of sample groups in the scores plot (Figure 3A).
As such, metabolite grouping along the x-axis are causal of
differences associated with the exercise intervention (e.g.,
histidine to the left, reduced with exercise, and progesterone
to the right, increased with exercise); whereas metabolites on
the y-axis are more indicative of differences in rested genotype
but no change in exercised genotype. The distribution of
metabolites in Figure 2B reﬂect similar response clustering as
the HCA results (Figure 2A). Cluster groups in Figures 2A, 3B
are color-matched and the signiﬁcant CV coefﬁcients are
labelled to the HCA plot.

4 Discussion
The metabolic pathways associated with the disruption of
AMPK-glycogen interactions in vivo, despite clear phenotypic
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FIGURE 2
Hierarchical Cluster Analysis (HCA) dendrogram of identiﬁed/annotated metabolites. (A) Agglomerative clustering of individual metabolites
based on pairwise correlation is shown. The lowest linkages within the HCA dendrogram indicate metabolites that display similar relative responses
between the experimental groups. Six clusters were observed. Metabolite labels are colored to reﬂect the results of the two-way ANOVA after
ﬁltering using a false discovery rate (FDR) of 0.1 (red = signiﬁcant effect of condition only; magenta = signiﬁcant effect of genotype and
condition; black = no signiﬁcance or FDR >0.1). *: Metabolites that signiﬁcantly (p < 0.05) contributed to the model along canonical variate 1 (CV1,
Figure 3A); #: Metabolites that signiﬁcantly (p < 0.05) contributed to the model along CV2. (B) Z-scores plot of the mean responses for each
metabolite cluster. After conversion of individual metabolite log10 responses to a z-score, the average response of each cluster was calculated and
presented here as a group error bar plot. Error bars indicate the standard error for each group mean (Red = WT; Blue = DKI). Following two-way
ANOVA, only Clusters C and F showed signiﬁcant differences in the averaged group metabolite response. Cluster C showed a signiﬁcant effect of
exercise for both genotypes (p = 2 × 10−5), and Cluster F showed a signiﬁcant interaction between genotype and exercise (p = 4 × 10−4) such that the
WT metabolite levels remained constant and the DKI metabolite levels signiﬁcantly decreased in response to exercise.
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FIGURE 3
Principal Component-Canonical Variates Analysis (PC-CVA) showing system-wide metabolite proﬁle differences between genotype at rest and
after exercise. (A) Scores plot of Canonical Variate 1 (CV1) vs. Canonical Variate 2 (CV2). Each point (circle, square or triangle) represents a single
sample [WT-Rest (n = 8), WT-Ex (n = 9), DKI-Rest (n = 10), DKI-Ex (n = 9)]. The mean (x) of each group is surrounded by a 95% conﬁdence interval of
the mean (full-line circles) and 95% conﬁdence interval of membership in each sample group (dashed-line circles). Sample group means are
considered signiﬁcantly different when the 95% conﬁdence interval of the means do not overlap. (B) The loading plot shows the inﬂuence (model
coefﬁcient value) of each metabolite that signiﬁcantly (p < 0.05) contributes to the separation observed in the scores plot. The direction of the
coefﬁcient vector maps directly to the direction of the data points in the scores plot relative to the origin.

increased adiposity and total body mass, and reduced voluntary
ambulatory activity versus WT mice (Janzen et al., 2021).
During exercise, cellular energy demand increases. While
lipids are the primary fuel source at rest and during low intensity
exercise (<50–60% VO2 max), carbohydrates utilization
dominates at higher intensities (>70–75% VO2 max (van
Loon et al., 2001; Hargreaves and Spriet, 2020). When
exercise is prolonged or under conditions of low carbohydrate
availability, amino acid contribution as fuel source is increased
(Howarth et al., 2010). Steroid hormones such as the

DKI mice evidenced a larger metabolome difference than the
WT mice between rest and post-exercise conditions (Figure 3B).
These differences support our working hypothesis that
differences in substrate utilization and/or availability
contribute to the overall phenotypic differences between DKI
and WT mice. The PC-CVA CV1 scores for the rested DKI mice
are further away from all exercised mice than the rested WT
mice. This indicates that DKI mice may have a more “sedentary”
resting metabolic phenotype compared to WT mice. This is
supported by previous ﬁndings showing that DKI mice exhibit
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mechanisms underlying decreased plasma pantothenic acid
levels in DKI versus WT mice remain unclear in the present
study, this may involve potential differences in gut
microbiome between genotypes, as pantothenic acid is
produced by gut bacteria (Magnusdottir et al., 2015;
Yoshii et al., 2019) and changes in the gut microbiome
can impair pantothenic acid production (Gominak, 2016).
Given the inﬂuence of gut microbiota on glucose metabolism
and skeletal muscle function in mice (Nay et al., 2019),
further
research
characterizing
gut
microbiome
composition would help determine its potential
contribution to the phenotypic differences observed in
DKI versus WT mice including impaired maximal
running speed [Figure 1B; (Janzen et al., 2022)], increased
adiposity [Figure 1D; (Janzen et al., 2021)], glucose
intolerance (Janzen et al., 2021) and changes in wholebody and skeletal muscle fuel utilization (Janzen et al.,
2021; Janzen et al., 2022). Reduced pantothenic acid
availability may also be associated with reduced free
CoASH (Robishaw and Neely, 1985) and/or availability of
subcellular pools of CoASH in skeletal muscle. Given the
numerous critical roles of CoASH in energy metabolism,
CoASH has been suggested as a potential limiting factor of
substrate utilization and exercise capacity (Whitﬁeld et al.,
2021). The potential contribution of decreased skeletal
muscle free CoASH to the decreased whole-body rates of
fat oxidation and increased rates of carbohydrate oxidation
observed in DKI versus WT mice (Janzen et al., 2021)
remains unclear. Future research investigating CoASH
species in skeletal muscle and its cytosolic and
mitochondrial compartments is therefore warranted to
determine their potential association with these
phenotypic differences between DKI and WT mice.
A total of 17 metabolites were signiﬁcantly different in
association with exercise (Table 2). Although these were
primarily metabolites that were expected to change with
exercise (e.g., lipid species, amino acids and steroid
hormones), it is worth noting two metabolites that have not
been previously reported in association with exercise.
N-acetyltryptophan is produced from tryptophan by the gut
microbiota (Pavlova et al., 2017; Bihlmeyer et al., 2021) and
exhibited a signiﬁcant increase in association with exercise in
both genotypes (Cluster C, Figure 2B). While the physiological
consequences of these increases are not known, recent research
supports the exchange of metabolites between the bloodstream
and the guts (Tabone et al., 2021) and an exercise-induced bidirectional crosstalk (Mach et al., 2021). Glycerophospho-Npalmitoyl ethanolamine (GP-NPEA) is a glycerophospholipid
membrane constituent with signal transduction roles via
palmitoylethanolamide (Zhang et al., 2018). The mechanisms
underlying changes in these plasma metabolites following
exercise are unclear and further investigations are required to
pinpoint their potential roles in exercise metabolism.

glucocorticoid corticosterone increase during times of
physiological energy stress, such as exercise, and promote
energy store mobilization by stimulating lipolysis,
gluconeogenesis and protein breakdown (Girard and Garland,
2002). Exercise-induced lipolysis leads to increased circulating
levels of free fatty acids and is also associated with increased
acylcarnitines (Hargreaves and Spriet, 2020; Belhaj et al., 2021);
this has also been shown in a recent investigation of rat plasma
metabolomic responses to acute aerobic exercise (Overmyer
et al., 2015). Both WT and DKI exhibited exercise-associated
increases in steroid hormones and acylcarnitines (Cluster C).
While we previously showed that DKI mice have decreased levels
of whole-body lipid oxidation during fasting (Janzen et al., 2021)
and submaximal exercise (Janzen et al., 2022), the present
ﬁndings reveal no differences in lipid mobilization responses
(both at rest and exercise) between the two genotypes. However, a
more detailed lipid proﬁle analysis may help establish potential
differences in lipid utilization between genotypes.
Our previous ﬁndings also showed that DKI mice had
increased depletion of skeletal muscle glycogen and increased
reliance on carbohydrate oxidation during exercise relative to
WT mice (Janzen et al., 2022). In the present study, a signiﬁcant
interaction (p = 3.53 × 10−4 ) was observed between genotype and
exercise in amino acids (Cluster F), with DKI mice evidencing
greater amino acid uptake and/or utilization in DKI versus WT
mice in association with exercise (Figure 2B). Together, these
observations may explain the reduced maximal exercise capacity
in DKI versus WT mice (Figure 1B), as increased amino acid
catabolism can help sustain the energy demands of exercise when
preferred fuel sources decrease (Lewis et al., 2010; Stander et al.,
2018), causing reduced exercise capacity. Speciﬁcally, decreased
ketogenic (leucine and lysine) and glucogenic (histidine,
arginine, proline, methionine) amino acids, and isoleucine
(ketogenic and glucogenic) are generally reduced following
exercise in blood and tissue samples from humans
(Contrepois et al., 2020; Schranner et al., 2020) and rodents
(Overmyer et al., 2015). Decreased amino acids may reﬂect
increased ketogenesis and gluconeogenesis permitting
continuous energy conversion when carbohydrate availability
is reduced, as observed in DKI versus WT mice following exercise
(Janzen et al., 2022). The precise mechanisms by which
disrupting AMPK-glycogen interaction results in differential
amino acid metabolism remain unclear and require further
investigation.
The Cluster F metabolite pantothenic acid (vitamin B5)
was signiﬁcantly decreased in DKI versus WT plasma, and
following exercise versus rest in both genotypes despite no
interaction between genotype and exercise status.
Pantothenic acid is a precursor for coenzyme A (CoASH),
which is involved in numerous metabolic reactions,
including energy metabolism and several steps in fatty
acid oxidation (Garland et al., 1970; Leonardi and
Jackowski, 2007; Watkins and Caballero, 2013). While the
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N-acetyltryptophan). Metabolic differences associated with
exercise were primarily explained by increased abundance of
acylcarnitines and steroid hormones, and decreased abundance
of amino acids. DKI mice displayed greater decrease in amino
acids following exercise, potentially indicating increased
utilization versus WT mice. DKI mice also displayed
decreased pantothenic acid levels, which may indicate
decreased levels of tissue pantothenic acid, a precursor of
CoASH involved in multiple steps of energy metabolism.
Whether the observed decrease in plasma pantothenic acid is
associated with decreased CoASH in skeletal muscle is
unknown, and further research is warranted to determine
the potential contribution to differences in substrate
utilization and exercise capacity observed in DKI versus WT
mice. Future complementary investigation of the metabolome
in metabolically active tissues such as skeletal muscle will
provide further insights into the complex metabolite
responses to acute exercise and phenotypic effects of
disrupting
AMPK-glycogen
interactions
on
energy
homeostasis and exercise capacity.

While this study characterized plasma metabolomic
responses in DKI and WT plasma at rest and in response to
exercise, some limitations need to be acknowledged. First, the
metabolites reported in this study were limited to those that
could be identiﬁed/annotated using an in-house metabolite
library or based on MS/MS spectral patterns from external
databases. Accordingly, the scope of our biological
interpretations remains limited. Second, this study was
powered based on the detection of differences in maximal
running speed and may be insufﬁcient to detect subtle
effects in some metabolic pathways. Third, mice were
randomly allocated to each group in the fed state at the start
of the light cycle, meaning the timing of each mouse’s last food
intake may have been different, therefore potentially
contributing to variance in metabolite levels between mice at
rest and/or following exercise at the time of sample collection.
Fourth, to ensure sufﬁcient blood volume required for
metabolomic analyses could be collected via cardiac
puncture, CO2 exposure prior to euthanasia was utilised.
While this CO2 exposure could potentially impact plasma
pH and metabolites, all mice were subjected to the same
duration of CO2 exposure and we do not expect CO2
contributed
to
between-group
differences.
Finally,
metabolomics studies analyzing bioﬂuids such as plasma
cannot provide comprehensive insight in terms of
mechanistic regulation as, for many metabolites, little is
known regarding the release and/or uptake regulation into
tissues in response to a stimulus such as exercise. For
example, the potential association of reduced plasma
pantothenic acid levels in DKI mice with reduced skeletal
muscle CoASH levels and/or rates of fat oxidation remains
unclear, as we did not measure skeletal muscle metabolites in
the present study. Therefore, complementary future analyses of
metabolites in metabolically active tissues such as skeletal
muscle will allow more comprehensive insights into how
acute exercise and disruption of AMPK-glycogen binding
affects tissue and circulating metabolomic signatures in mice.
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investigate the effects of disrupting AMPK-glycogen
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2022), we demonstrate that DKI mice have increased total body
and fat mass, associated with reduced maximal running speed. A
total of 83 mouse plasma metabolites were identiﬁed/annotated, of
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hormones. This study also identiﬁed/annotated previously
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